DLH Holdings Corp DEFA14A, filed Mar 11, 2020
DLH Holdings Corp. (DLHC)
DEFA14A
2020-03-11
View Original
Added on
October 18, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant | ||||||||||||||||||||||||||
Filed by a Party other than the Registrant | ||||||||||||||||||||||||||
| Check the appropriate box: | ||||||||||||||||||||||||||
| | Preliminary Proxy Statement | |||||||||||||||||||||||||
| | Confidential, for Use of the Commission Only (as permitted by Rule 14a 6(e)(2)) | |||||||||||||||||||||||||
| | Definitive Proxy Statement | |||||||||||||||||||||||||
| | Definitive Additional Materials | |||||||||||||||||||||||||
| | Soliciting Material under §240.14a 12 | |||||||||||||||||||||||||
| DLH HOLDINGS CORP. | ||||||||||||||||||||||||||
| (Name of Registrant as Specified In Its Charter) | ||||||||||||||||||||||||||
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) | ||||||||||||||||||||||||||
| Payment of Filing Fee (Check the appropriate box): | ||||||||||||||||||||||||||
| | No fee required. | |||||||||||||||||||||||||
| | Fee computed on table below per Exchange Act Rules 14a 6(i)(1) and 0-11. | |||||||||||||||||||||||||
| (1) | Title of each class of securities to which transaction applies: | |||||||||||||||||||||||||
| (2) | Aggregate number of securities to which transaction applies: | |||||||||||||||||||||||||
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0 11 (set forth the amount on which the filing fee is calculated and state how it was determined): | |||||||||||||||||||||||||
| (4) | Proposed maximum aggregate value of transaction: | |||||||||||||||||||||||||
| (5) | Total fee paid: | |||||||||||||||||||||||||
| | Fee paid previously with preliminary materials. | |||||||||||||||||||||||||
| | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||||||||||||||||||||||||
| (1) | Amount Previously Paid: | |||||||||||||||||||||||||
| (2) | Form, Schedule or Registration Statement No.: | |||||||||||||||||||||||||
| (3) | Filing Party: | |||||||||||||||||||||||||
| (4) | Date Filed: | |||||||||||||||||||||||||
SEC 1913 (02-02) | Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | |||||||||||||||||||||||||
{N0253952 }
DLH to Webcast Annual Meeting and Host Conference Call
Allows for Greater Participation Given Current Coronavirus Environment
Atlanta, Georgia – March 11, 2020 - DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare services and solutions to federal agencies, today announced that it will host a conference call and webcast for its Annual Shareholder Meeting (to be held tomorrow, March 12, 2020 at 10:00 a.m. Eastern) to accommodate travel limitations and other factors related to current concerns tied to the Coronavirus. A presentation will be reviewed by management, and shareholders may participate live or listen to a replay afterwards.
Interested individuals may take part in the Annual Shareholder Meeting by joining the webcast or dialing 888-347-5290 or 412-317-5256. Presentation materials will be posted on the Investor Relations section of the DLH website prior to the commencement of the call. A digital recording of the conference call will also be available for replay two hours after completion and can be accessed on the DLH Investor Relations website or by dialing 877-344-7529 and entering the conference ID 10139452.
To attend in person, the address is as follows:
The Offices of Becker & Poliakoff, LLP
45 Broadway, 17th floor
New York, N.Y. 10006
About DLH
DLH (NASDAQ:DLHC) serves federal government clients throughout the United States and abroad delivering technology enabled solutions in key health and human services programs. The Company's seven core competencies include secure data analytics, clinical trials and laboratory services, case management, performance evaluation, system modernization, operational logistics and readiness, and strategic digital communications. DLH has over 1,950 employees serving numerous government agencies. For more information, visit the corporate website at
www.dlhcorp.com
CONTACTS:
INVESTOR RELATIONS
Contact: Chris Witty
Phone: 646-438-9385
Email: cwitty@darrowir.com
{N0253952 }